Omeros Corporation

Seattle,  WA 
United States
  • Booth: 519

Omeros is a biopharmaceutical company committed to discovering, developing and commercializing first-in-class small molecule and protein therapeutics across a diverse range of disorders for orphan and large-market indications. In partnership with physicians, regulators, and patients and their families, Omeros is focused on developing effective, safe therapeutics in serious diseases to improve or save the lives of patients who are suffering. 


Contact the Tandem Meetings of ASTCT & CIBMTR Office at

For Technical Support with this webpage, please contact support.